Endoscopic approaches to obesity

Digestive Diseases

Volumn 30, Issue 2, 2012, Pages 187-195

  Štimac, Davor ^a   Majanović, Sanja Klobučar ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Botulinum toxin; Endoluminal interventions; Endoscopic techniques; Intragastric balloon; Malabsorptive procedures; Obesity treatment; Restrictive procedures

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

BALLOON; BARIATRIC SURGERY; BYPASS SURGERY; COMORBIDITY; DIABETES MELLITUS; DUODENOJEJUNAL BYPASS SLEEVE; DUODENUM; ELECTROSTIMULATION THERAPY; ENDOLUMINAL VERTICAL GASTROPLASTY; ENDOPROSTHESIS; ENDOSCOPIC SURGERY; FOOD INTAKE; GASTRIC ELECTRICAL STIMULATION; GASTRODUODENOJEJUNAL BYPASS SLEEVE; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; HUMAN; IMPLANT; JEJUNUM; MEDICAL DEVICE; MORBID OBESITY; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; OBESITY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULSE GENERATOR; REOPERATION; REVIEW; RISK REDUCTION; STAPLER; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SUTURE; SUTURING METHOD; TRANSORAL ENDOSCOPIC RESTRICTIVE IMPLANT SYSTEM; TRANSORAL GASTROPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ELECTRIC STIMULATION; ENDOSCOPY; GASTRIC BALLOON; HUMANS; MALABSORPTION SYNDROMES; NATURAL ORIFICE ENDOSCOPIC SURGERY; OBESITY;

EID: 84862892677     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000336683     Document Type: Review

References (41)

1. Hankey CR: Weight-loss interventions in the treatment of obesity. Nutr Soc 2010; 69: 34-38.
2. Robinson MK: Surgical treatment of obesity -weighing the facts. N Engl J Med 2009; 361: 520-521.
3. Morino M, Toppino M, Forestieri P, et al: Mortality after bariatric surgery: analysis of 13871 morbidly obese patients from a national registry. Ann Surg 2007; 246: 1002-1007.
4. Coté GA, Edmundowicz SA: Emerging technology: endoluminal treatment of obesity. Gastrointest Endosc 2009; 70: 991-999.
5. Kumar N, Thompson CC: Endoscopic solutions for weight loss. Curr Opin Gastroenterol 2011; 27: 407-411.
6. Thompson CC: Endoscopic therapy of obesity: a new paradigm in bariatric care. Gastrointest Endosc 2010; 72: 505-507.
7. Ryou M, Ryan MC, Thompson CC: Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest Endosc Clin N Am 2011; 21: 315-333.
8. Melissas J, Mouzas J, Fills D, et al: The intragastric balloon -smoothing the path to bariatric surgery. Obes Surg 2006; 16: 897-902.
9. Spyropolos C, Katsakoulis E, Mead N, et al: Intragastric balloon for high-risk superobese patients: a prospective analysis of efficacy. Surg Relat Dis 2007; 3: 78-83.
10. Genco A, Bruni T, Doldi SB, et al: BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg 2005; 15: 1161-1164.
11. Lopez-Nava G, Rubio MA, Prados S, et al: BioEnterics intragastric balloon (BIB). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011; 21: 5-9.
12. Stimac D, Majanovic SK, Turk T, Kezele B, Licul V, Orlic ZC: Intragastric balloon treatment for obesity: results of a large single center prospective study. Obes Surg 2011; 21: 551-555.
13. Dastis NS, François E, Deviere J, Hittelet A, Ilah Mehdi A, Barea M, Dumonceau JM: Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009; 41: 575-580.
14. Kadirkamanathan SS, Evans DF, Gong F, Yazaki E, Scott M, Swain CP: Antireflux operations at flexible endoscopy using endoluminal stitching techniques: an experimental study. Gastrointest Endosc 1996; 44: 133-143.
15. Rothstein RI, Filipi CJ: Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am 2003; 13: 89-101.
16. Schwartz MP, Wellink H, Gooszen HG, et al: Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut 2007; 56: 20-28.
17. Fogel R, De Fogel J, Bonilla Y, et al: Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year followup in 64 patients. Gastrointest Endosc 2008; 68: 51-58.
18. Thompson CC, Brethauer SA, Chand B, et al: Transoral gastric volume reduction as an intervention for weight management (TRIM) multicenter feasibility study: a report of early outcomes. Gastroenterology 2009; 136: A-384.
19. Devière J, Ojeda Valdes G, Cuevas Herrera L, et al: Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study. Surg Endosc 2008; 22: 589-598.
20. Moreno C, Closset J, Dugardeyn S, et al: Transoral gastroplasty is safe, feasible and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy 2008; 40: 406-413.
21. Chiellini C, Iaconelli A, Familiari P, Riccioni ME, Castagneto M, Nanni G, Costamagna G, Mingrone G: Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects. Nutr Metab Cardiovasc Dis 2010; 20: 202-207.
22. de Jong K, Mathus-Vliegen EMH, Veldhuyzen EAML, et al: Short-term safety and efficacy of the Trans-Oral Endoscopic Restrictive Implant System for the treatment of obesity. Gastrointest Endosc 2010; 72: 497-504.
23. Verlaan T, de Jong K, Mathus-Vliegen EM, et al: Evaluation of the safety and efficacy results of the Trans-Oral Endoscopic Restrictive System (TERIS) for the treatment of obesity at six months (Mo270); presented at Digestive Disease Week, Chicago, May 2011.
24. Ellsmere JC, Thompson CC, Brugge WR, Chuttani R, Desilets DJ, Rattner DW, Tarnoff ME, Kaplan LM: Endoscopic interventions for weight loss surgery. Obesity 2009; 17: 929-933.
25. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, et al: First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4: 55-59.
26. Tarnoff M, Rodriguez L, Escalona A, et al: Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc 2009; 23: 650-656.
27. De Moura EG, Martins BC, Lopes GS, et al: Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 2011; 14: 183-189.
28. Sandler BJ, Rumbaut R, Swain CP, et al: Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc 2011; 25: 3028-3033.
29. Gui D, Mingrone G, Valenza V, et al: Effect of botulinum toxin antral injection on gastric emptying and weight rediction in obese patients: a pilot study. Aliment Pharmacol Ther 2006; 23: 675-680.
30. Mittermair R, Keller C, Geibel J: Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg 2007; 17: 732-736.
31. Foschi D, Corsi F, lazzaroni M, et al: Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes (Lond) 2007; 31: 707-712.
32. Garcia-Compean D, Garza HM: Intragastric injection of botulinum toxin for the treatment of obesity. Where are we? World J Gastroenterol 2008; 14: 1805-1809.
33. Xu X, Pasricha PJ, Chen JD: Feasibility of gastric electrical stimulation by use of endoscopically placed electrodes. Gastrointest Endosc 2007; 66: 981-986.
34. Sallam HS, Chen JD, Pasricha PJ: Feasibility of gastric electrical stimulation by percutaneous endoscopic transgastric electrodes. Gastrointest Endosc 2008; 68: 754-759.
35. Sanmiguel CP, Conklin JL, Cunneen SA, et al: Gastric electrical stimulation with the TANTALUS system in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol 2009; 3: 964-970.
36. Camilleri M, Toouli J, Herrera MF, et al: Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 2008; 143: 723-731.
37. Fernandez-Esparrach G, Cordova H, Bordas JM, et al: Endoscopic management of the complications of the bariatric surgery. Experience of more than 400 interventions. Gastroenterol Hepatol 2011; 34: 131-136.
38. Schauer P, Chand B, Brethauer S: New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc 2007; 21: 347-356.
39. Hawes R: ASGE/SAGES Working Group on Natural Orifice Transluminal Endoscopic Surgery. Gastrointest Endosc 2006; 63: 199-203.
40. Tsesmeli N, Coumaros D: The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery. Endoscopy 2010; 42: 155-162.
41. Ho KY, Phee LS, Kencana AP, et al: Ingestible wireless capsule for treatment of obesity (Mo1348); presented at Digestive Disease Week, Chicago, May 2011.